Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +109.5% | -7.2% | 2 / 3 | +28.0% | -0.25 pp | +10.23 pp | +11.1% | 0.05 | 8.37 | 304 | +28,0% | 2,2 | +109,9% | 8.37 | 4.86 | +72,1% |
| Pts | 12 | 0 | 8 | 12 | 4 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 12.600 (close price on 2026-10-19)EPS (TTM): 1.506
Financial charts
1.Revenue & growth
VND bn304Q2/26
1.Revenue & growth
VND bn304Q2/26
2.Profit & growth
VND bn2,24Q2/26
3.Profit mix (Penman)
VND bn50,9Q2/26
4.Margins & cost structure
%17.3%Q2/26
5.Returns & cash cycle
% · days29.9%Q2/26
6.Earnings quality & cash
VND bn115Q2/26
7.Asset structure
VND bn683Q2/26
8.Funding & debt health
VND bn · times683Q2/26
9.Revenue backlog
VND bn49,2Q2/26
10.Valuation
times · %8,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %85Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-67.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26